Our Technology

Sustainably producing advanced pharmaceutical and agricultural solutions

BSI has innovated a proprietary method of producing advanced botanical materials required to produce QS-21, the Gold Standard vaccine adjuvant for human immune system activation, and for the highly effective biofungicide Quillibrium® which protects a wide variety of fruits and vegetable crops from a range of pathogens, including Botrytis, Alternaria, Sour Rot and Powdery Mildew. 

Exotic trees are the key

These pharma and agricultural products are derived from exotic and legally protected trees growing in Chile, known as Quillaja saponaria.
 
BSI grows the Quillaja saponaria trees right in their own labs, located in Santiago, Chile and Davis, California.

Quillaja saponaria photo
Quillaja saponaria leaves

Sustainable technology

Without cutting down any trees, BSI is producing a virtually unlimited supply of advanced botanical materials (ABM), meeting the vaccine market requirements of pharma spec GMP QS-21, as well as Quillibrium® biofungicide for sustainable agriculture.

How it works

How does BSI do it?

When the trees are in vitro, BSI scientists extract the active ingredients to produce the advanced botanical materials needed for QS-21 vaccine adjuvant and Quillibrium® biofungicide.

Today, BSI is growing and extracting from the Quillaja saponaria, but our robust pipeline includes future products coming from other exotic trees grown in various regions of the world, from North and South America to Europe, Asia, and the Antarctic.

REady to learn more?

Get in touch with BSI